GV Health, an insurtech start-up that analyses vast quantities of patient data to identify predictive trends, has achieved a $1.2bn valuation. The announcement follows $130m of investment into the company from Clover, Alphabet's venture arm. By identifying gaps in patients' care, GV's software can predict upcoming health issues and dispatch one of its nurses to gauge the need for treatment. Currently only operating in New Jersey, the start-up will use the funding to expand to three more states by October.
Clover Health, an insurtech start-up that analyses vast quantities of patient data to identify predictive trends, has achieved a $1.2bn valuation. The announcement follows $130m of investment into the company from GV, Alphabet's venture arm. By identifying gaps in patients' care, Clover's software can predict upcoming health issues and dispatch one of its nurses to gauge the need for treatment. Currently only operating in New Jersey, the start-up will use the funding to expand to three more states by October.